Inhibition of NF-κB activity prevents downregulation of α1-adrenergic receptors and circulatory failure during CLP-induced sepsis

Shock

Volumn 32, Issue 3, 2009, Pages 239-246

  Schmidt, Christoph ^a   Kurt, Birgül ^a   Höcherl, Klaus ^a   Bucher, Michael ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

1 adrenergic receptor; NF B; Proinflammatory cytokines; Sepsis

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUCIFERASE; NORADRENALIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; HEMODYNAMIC PARAMETERS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ANIMAL; C57BL MOUSE; CECUM; CELL CULTURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; HEMODYNAMICS; INJURY; LIGATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; RNA STABILITY; SEPSIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CECUM; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEMODYNAMICS; INTERFERON-GAMMA; INTERLEUKIN-1; INTERLEUKIN-6; LIGATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, ADRENERGIC, ALPHA-1; RNA STABILITY; RNA, SMALL INTERFERING; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69549110069     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181994752     Document Type: Article

References (34)

1. Parrillo JE: Pathogenetic mechanisms of septic shock. New Engl J Med 328:1471-1477, 1993.
2. Russell JA: Management of sepsis. New Engl J Med 355:1699-1713, 2006.
3. Chernow B, Rainey TG, Lake CR: Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 10:409-416, 1982.
4. Wray GM, Coakley JH: Severe septic shock unresponsive to noradrenaline. Lancet 346:1604, 1995.
5. Altavilla D, Squadrito G, Minutoli L, Deodato B, Bova A, Sardella A, Seminara P, Passaniti M, Urna G, Venuti SF, et al.: Inhibition of nuclear factor-kappaB activation by IRFI 042, protects against endotoxin-induced shock. Cardiovasc Res 54:684-693, 2002. (Pubitemid 34595428)
6. Ikezoe T, Yang Y, Heber D, Taguchi H, Koeffler HP: PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharideinduced septic shock. Mol Pharmacol 64:1521-1529, 2003. (Pubitemid 37532241)
7. Sheehan M, Wong HR, Hake PW, Zingarelli B: Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Crit Care Med 31:2263-2270, 2003. (Pubitemid 37100827)
8. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179, 1994. (Pubitemid 2081202)
9. Liu SF, Malik AB: NF-Kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290: L622-L645, 2006.
10. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10:405-455, 1994.
11. Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T: Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension 30:35-41, 1997. (Pubitemid 27306344)
12. Bucher M, Hobbhahn J, Taeger K, Kurtz A: Cytokine-mediated down-regulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol 282:R979-R984, 2002. (Pubitemid 34664548)
13. Bucher M, Ittner KP, Hobbhahn J, Taeger K, Kurtz A: Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension 38:177-182, 2001. (Pubitemid 34224740)
14. Bucher M, Kees F, Taeger K, Kurtz A: Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med 31: 566-571, 2003. (Pubitemid 36232956)
15. Bucher M, Taeger K: Endothelin-receptor gene-expression in rat endotoxemia. Intensive Care Med 28:642-647, 2002.
16. Gurantz D, Cowling RT, Varki N, Frikovsky E, Moore CD, Greenberg BH: IL- 1Beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post- MI heart. J Mol Cell Cardiol 38:505-515, 2005. (Pubitemid 40331941)
17. Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J: Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci U S A 101:14883-14888, 2004. (Pubitemid 39410769)
18. Schmidt C, Hocherl K, Kurt B, Bucher M: Role of NF-kappaB-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure. Crit Care Med 36:2363-2372, 2008.
19. Albuszies G, Vogt J, Wachter U, Thiemermann C, Leverve XM, Weber S, Georgieff M, Radermacher P, Barth E: The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock. Intensive Care Med 33:1094-1101, 2007. (Pubitemid 46835419)
20. Schmidt C, Hocherl K, Schweda F, Kurtz A, Bucher M: Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol 18: 1072-1083, 2007. (Pubitemid 46536893)
21. Bucher M, Hobbhahn J, Kurtz A: Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med 29:1750-1755, 2001. (Pubitemid 32848376)
22. Klar J, Sigl M, Obermayer B, Schweda F, Kramer BK, Kurtz A: Calcium inhibits Renin gene expression by transcriptional and posttranscriptional mechanisms. Hypertension 46:1340-1346, 2005. (Pubitemid 43189733)
23. Graham RM, Perez DM, Hwa J: α1-adrenergic receptor subtypes: molecular structure, function, and signaling. Circ Res 78:737-749, 1996. (Pubitemid 126424512)
24. Guimaraes S, Moura D: Vascular adrenoceptors: an update. Pharmacol Rev 53:319-356, 2001.
25. Parker SJ, Watkins PE: Experimental models of gram-negative sepsis. Br J Surg 88:22-30, 2001.
26. Abraham E: Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 25:556-566, 1999.
27. Briegel J, Jochum M, Gippner-Steppert C, Thiel M: Immunomodulation in septic shock[colon] hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol 17:S70-S74, 2001. (Pubitemid 32119058)
28. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H: Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167:512-520, 2003.
29. Arnalich F, Garcia-Palomero E, Lopez J, Jimenez M, Madero R, Renart J, Vazquez JJ, Montiel C: Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68:1942-1945, 2000.
30. Bohrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D, Bottiger BW, Stern DM, Waldherr R, Saeger HD, et al.: Role of NFkappaB in the mortality of sepsis. J Clin Invest 100:972-985, 1997.
31. Pocock J, Gomez-Guerrero C, Harendza S, Ayoub M, Hernandez-Vargas P, Zahner G, Stahl RA, Thaiss F: Differential activation of NF-kappa B, AP-1, and C/EBP in endotoxin-tolerant rats: mechanisms for in vivo regulation of glomerular RANTES/CCL5 expression. J Immunol 170: 6280-6291, 2003. (Pubitemid 36682614)
32. Pritts TA, Moon MR, Wang Q, Hungness ES, Salzman AL, Fischer JE, Hasselgren PO: Activation of NF-kappaB varies in different regions of the gastrointestinal tract during endotoxemia. Shock 14:118-122, 2000.
33. Moon SK, Cha BY, Kim CH: ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. J Cell Physiol 198:417-427, 2004.
34. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M, Kikugawa K: Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22:3356-3366, 2003. (Pubitemid 36834865)